Stocktoria
Werewolf Therapeutics, Inc. HOWL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-04-30
Werewolf Therapeutics, Inc. statistics & valuation
Market cap$15.7M
P / B0.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -87.6% | -55.6% | -21.4% | -33.6% | -27.9% |
| Return on equity | -245.2% | -96.1% | -33.6% | -44.0% | -32.7% |
| Debt / equity | 1.29× | 0.44× | 0.36× | — | — |
| Current ratio | 1.62 | 7.45 | 7.14 | 5.84 | 13.56 |
Source: SEC EDGAR filings · CIK 0001785530 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.